Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2023 | 1 |
2024 | 2 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Clinical characteristics of patients with metastatic castration-resistant prostate cancer after treatment with combined androgen blockade.
BMC Urol. 2023 Apr 28;23(1):74. doi: 10.1186/s12894-023-01233-6.
BMC Urol. 2023.
PMID: 37118708
Free PMC article.
Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries.
Obinata D, Takayama K, Inoue S, Takahashi S.
Obinata D, et al.
Int J Urol. 2024 Feb 12. doi: 10.1111/iju.15424. Online ahead of print.
Int J Urol. 2024.
PMID: 38345202
Review.
Item in Clipboard
Low reduction of prostate volume is a significant predictor of prostate cancer at subsequent biopsy in patients with dutasteride: A retrospective study.
Obinata D, Suzuki S, Yamanaka Y, Yoshizawa T, Mochida J, Yamaguchi K, Takahashi S.
Obinata D, et al.
Andrologia. 2020 Dec;52(11):e13810. doi: 10.1111/and.13810. Epub 2020 Aug 20.
Andrologia. 2020.
PMID: 32816374
Free PMC article.
Item in Clipboard
Patient-derived castration-resistant prostate cancer model revealed CTBP2 upregulation mediated by OCT1 and androgen receptor.
Obinata D, Takayama K, Lawrence MG, Funakoshi D, Hara M, Niranjan B, Teng L, Taylor RA, Risbridger GP, Takahashi S, Inoue S.
Obinata D, et al.
BMC Cancer. 2024 May 2;24(1):554. doi: 10.1186/s12885-024-12298-3.
BMC Cancer. 2024.
PMID: 38698344
Free PMC article.
Item in Clipboard
Cite
Cite